These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 7520416)
1. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa. Hatano K; Boisot S; DesJardins D; Wright DC; Brisker J; Pier GB Infect Immun; 1994 Sep; 62(9):3608-16. PubMed ID: 7520416 [TBL] [Abstract][Full Text] [Related]
2. Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains. Hatano K; Pier GB Infect Immun; 1998 Aug; 66(8):3719-26. PubMed ID: 9673254 [TBL] [Abstract][Full Text] [Related]
3. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Hatano K; Goldberg JB; Pier GB Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730 [TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Theilacker C; Coleman FT; Mueschenborn S; Llosa N; Grout M; Pier GB Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072 [TBL] [Abstract][Full Text] [Related]
5. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06. Pier GB; Koles NL; Meluleni G; Hatano K; Pollack M Infect Immun; 1994 Apr; 62(4):1137-43. PubMed ID: 8132318 [TBL] [Abstract][Full Text] [Related]